Martine A Rothblatt sold $4.6M of UTHR
Chairperson & CEO at UNITED THERAPEUTICS Corp. 9,500 shares at an average of $480.85, traded Sep 28, 2026, filed Sep 29, 2026.
Score components
- +25RoleCEO
- +25Trade size$4.6M at market
- 0Share of holdings soldSold 2.8% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001106578-26-000151, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 28, 2026 | MOption exercise Common Stockindirect: by Trust10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 | 12 d ago |
| Sep 28, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -280 | $472.43 | $132k | 333,663 | 12 d ago |
| Sep 28, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -600 | $473.28 | $284k | 333,063 | 12 d ago |
| Sep 28, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -680 | $474.46 | $323k | 332,383 | 12 d ago |
| Sep 28, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -80 | $475.28 | $38k | 332,303 | 12 d ago |
| Sep 28, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -160 | $476.68 | $76k | 332,143 | 12 d ago |
| Sep 28, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -200 | $477.45 | $95k | 331,943 | 12 d ago |
| Sep 28, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -601 | $479.06 | $288k | 331,342 | 12 d ago |
| Sep 28, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -1,013 | $480.18 | $486k | 330,329 | 12 d ago |
| Sep 28, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -1,354 | $481.20 | $652k | 328,975 | 12 d ago |
| Sep 28, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -693 | $482.11 | $334k | 328,282 | 12 d ago |
| Sep 28, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -1,539 | $483.20 | $744k | 326,743 | 12 d ago |
| Sep 28, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -825 | $484.47 | $400k | 325,918 | 12 d ago |
| Sep 28, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -1,315 | $485.45 | $638k | 324,603 | 12 d ago |
| Sep 28, 2026 | SOpen-market sale Common Stockindirect: by Trust10b5-1 | -160 | $486.01 | $78k | 324,443 | 12 d ago |
| Sep 28, 2026 | MOption exercise Stock Optionderivativeindirect: by Trust10b5-1 | -9,500 | $0.00 | $0 | 347,410 | 12 d ago |
Related signals
Other insiders at UNITED THERAPEUTICS Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.1M 9,500 shares | -3% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.2M 9,500 shares | -3% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.1M 9,500 shares | -3% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.1M 9,500 shares | -3% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.2M 9,500 shares | -3% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $5.5M 9,500 shares | -3% | |
| 18Weak | UNITED THERAPEUTICS Corp | Paul A Mahon EVP & GENERAL COUNSEL | $4.7M 8,300 shares | -16% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $3.9M 7,580 shares | -2% | |
| 38Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $1.1M 1,920 shares | -1% | |
| 23Weak | UNITED THERAPEUTICS Corp | Martine A Rothblatt Chairperson & CEO | $4.5M 9,500 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.